Ufp Technologies (UFPT) Free Cash Flow Growth (1y) (2011 - 2026)
Ufp Technologies (UFPT) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -14.34% |
| 10 | Ufp Technologies | 2.39 Bn | 2.38 Bn | 50.92 Mn | -35.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30.53% |
| Mar 31, 2026 | -70.85% |
| Dec 31, 2025 | -31.06% |
| Sep 30, 2025 | 97.25% |
| Jun 30, 2025 | 151.30% |
| Mar 31, 2025 | 23.21% |
| Dec 31, 2024 | 19.52% |
| Sep 30, 2024 | 38.30% |
| Jun 30, 2024 | 46.49% |
| Mar 31, 2024 | 2,056.58% |
| Dec 31, 2023 | 36.93% |
| Sep 30, 2023 | 729.39% |
| Jun 30, 2023 | 304.39% |
| Mar 31, 2023 | 91.78% |
| Dec 31, 2022 | 3,072.91% |
| Sep 30, 2022 | -186.69% |
| Jun 30, 2022 | -163.28% |
| Mar 31, 2022 | -394.43% |
| Dec 31, 2021 | -107.18% |
| Sep 30, 2021 | -45.15% |